BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

856 related articles for article (PubMed ID: 15529165)

  • 1. Recombinant protein folding and misfolding in Escherichia coli.
    Baneyx F; Mujacic M
    Nat Biotechnol; 2004 Nov; 22(11):1399-408. PubMed ID: 15529165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein expression and refolding--a practical guide to getting the most out of inclusion bodies.
    Cabrita LD; Bottomley SP
    Biotechnol Annu Rev; 2004; 10():31-50. PubMed ID: 15504702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles and applications of small heat shock proteins in the production of recombinant proteins in Escherichia coli.
    Han MJ; Park SJ; Park TJ; Lee SY
    Biotechnol Bioeng; 2004 Nov; 88(4):426-36. PubMed ID: 15382106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ protein folding and activation in bacterial inclusion bodies.
    Gonzalez-Montalban N; Natalello A; García-Fruitós E; Villaverde A; Doglia SM
    Biotechnol Bioeng; 2008 Jul; 100(4):797-802. PubMed ID: 18351678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced genetic strategies for recombinant protein expression in Escherichia coli.
    Sørensen HP; Mortensen KK
    J Biotechnol; 2005 Jan; 115(2):113-28. PubMed ID: 15607230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DnaK and DnaJ facilitated the folding process and reduced inclusion body formation of magnesium transporter CorA overexpressed in Escherichia coli.
    Chen Y; Song J; Sui SF; Wang DN
    Protein Expr Purif; 2003 Dec; 32(2):221-31. PubMed ID: 14965767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-free production of aggregation-prone proteins in soluble and active forms.
    Kang SH; Kim DM; Kim HJ; Jun SY; Lee KY; Kim HJ
    Biotechnol Prog; 2005; 21(5):1412-9. PubMed ID: 16209544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression, renaturation and simultaneous purification of recombinant human stem cell factor in Escherichia coli.
    Lili W; Chaozhan W; Xindu G
    Biotechnol Lett; 2006 Jul; 28(13):993-7. PubMed ID: 16786266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting protein refolding yields in a fed-batch and batch-refolding system.
    Mannall GJ; Titchener-Hooker NJ; Dalby PA
    Biotechnol Bioeng; 2007 Aug; 97(6):1523-34. PubMed ID: 17304557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The twin-arginine translocation system and its capability for protein secretion in biotechnological protein production.
    Brüser T
    Appl Microbiol Biotechnol; 2007 Aug; 76(1):35-45. PubMed ID: 17476499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chaperone-based procedure to increase yields of soluble recombinant proteins produced in E. coli.
    de Marco A; Deuerling E; Mogk A; Tomoyasu T; Bukau B
    BMC Biotechnol; 2007 Jun; 7():32. PubMed ID: 17565681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant protein secretion in Escherichia coli.
    Mergulhão FJ; Summers DK; Monteiro GA
    Biotechnol Adv; 2005 May; 23(3):177-202. PubMed ID: 15763404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoplasmic overexpression, folding, and processing of penicillin acylase precursor in Escherichia coli.
    Xu Y; Hsieh MY; Narayanan N; Anderson WA; Scharer JM; Moo-Young M; Chou CP
    Biotechnol Prog; 2005; 21(5):1357-65. PubMed ID: 16209538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inclusion body anatomy and functioning of chaperone-mediated in vivo inclusion body disassembly during high-level recombinant protein production in Escherichia coli.
    Rinas U; Hoffmann F; Betiku E; Estapé D; Marten S
    J Biotechnol; 2007 Jan; 127(2):244-57. PubMed ID: 16945443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced enzyme activities of inclusion bodies of recombinant beta-galactosidase via the addition of inducer analog after L-arabinose induction in the araBAD promoter system of Escherichia coli.
    Jung KH
    J Microbiol Biotechnol; 2008 Mar; 18(3):434-42. PubMed ID: 18388459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On-column refolding and purification of recombinant human interleukin-1 receptor antagonist (rHuIL-1ra) expressed as inclusion body in Escherichia coli.
    Tan H; Dan G; Gong H; Cao L
    Biotechnol Lett; 2005 Aug; 27(16):1177-82. PubMed ID: 16158260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baculoviral polyhedrin as a novel fusion partner for formation of inclusion body in Escherichia coli.
    Seo JH; Li L; Yeo JS; Cha HJ
    Biotechnol Bioeng; 2003 Nov; 84(4):467-73. PubMed ID: 14574705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in heterologous protein production in Escherichia coli.
    Hockney RC
    Trends Biotechnol; 1994 Nov; 12(11):456-63. PubMed ID: 7765545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing scaleup yield for protein production: Computationally Optimized DNA Assembly (CODA) and Translation Engineering.
    Hatfield GW; Roth DA
    Biotechnol Annu Rev; 2007; 13():27-42. PubMed ID: 17875472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A system for concomitant overexpression of four periplasmic folding catalysts to improve secretory protein production in Escherichia coli.
    Schlapschy M; Grimm S; Skerra A
    Protein Eng Des Sel; 2006 Aug; 19(8):385-90. PubMed ID: 16720693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.